Go to content




  • ABMI exhibits at MEDICA 2008 together with RMS and Tensys

  • ABMI signs large collaboration agreement with medtech leader in India RMS

  • ABMI moves its operational offices to Y-parc, Yverdon

  • ABMI starts collaboration with Technical Universities of Yverdon and Fribourg

  • ABMI obtains large public funding for R&D from the Swiss Government for finishing Embol-ID


  • ABMI applies for large public grant

  • ABMI exhibits at MEDICA 2007 with BioPack

  • ABMI advances developement of Embol-ID prototype #3

  • ABMI finishes working version of Embol-ID protoype #2


  • ABMI exhibits at MEDICA 2006

  • ABMI lauches evaluation program for the new, improved release of the Embol-STATION®, version 1.2

  • ABMI at 2006 ESNCH meeting in Düsseldorf

  • ABMI at 2006 ESC in Mannheim4

  • ABMI at Asolo meeting on emboli


  • ABMI exhibited at MEDICA 2005 (Düsseldorf, Germany).

  • ABMI successfully closes its first convertible bond submission following its opening to private investors.

  • ABMI receives the PERL Trophy for Exellence from Lausanne-Regions

  • ABMI attends the 2005 European Stroke Conference in Bologna (Italy). (ESC).

  • ABMI attends and exhibits at the 10th Meeting of the European Society for Neurosonology and Cerebral Hemodynamics (ESNCH).

  • ABMI expands its management team by hiring a COO and a CFO.

  • ABMI wins Platinum European Seal of Excellence

  • ABMI is granted a second loan from FIT (Fondation pour l'Innovation Technologique)


  • The ABMI story becomes an example of a successful business case at a leading business school, the IMD, in Lausanne

  • ABMI exhibits at MEDICA 2004 (Düsseldorf, Germany).

  • ABMI's CEO delivers talk on biomedical startups in the Salon des Affaires (Lausanne, Switzerland).

  • ABMI is awarded the 2004 de Vigier Award for Young Entrepreneurs.

  • ABMI participates in the 9th Meeting of the European Society of Neurosonology and Cerebral Hemodynamics (Wetzlar, Germany).

  • ABMI's CEO invited by Rezonance to talk on "HOW TO MARKET AND SELL PRODUCTS IN THE LIFE SCIENCES" on BioTuesday networking meeting.

  • ABMI starts its CTI Project in collaboration with the EIF (University of Applied Science in Fribourg).

and before

  • ABMI wins the Gold Medal for Technology, and ranks first in the Boitech-Medical category, of the Wall Street Journal Innovation Awards.

  • ABMI moves from the UNIL (Lausanne's University) to their new offices in the PSE (Scientific Park of the EPFL) located next to the EPFL (Swiss Federal Institute of Technology).

  • ABMI wins the Dr Liechti Encouragement Prize

  • ABMI is granted a first loan from FIT (Fondation pour l'Innovation Technologique)

  • CTI-Start-up starts ABMI's coaching. Today, ABMI is CTI certified.

  • ABMI is founded as a Swiss limited company (Société Anonyme) in Lausanne.

  • ABMI's BioMedical research project, which started in 1999, arrives at term.

  • Claudio Lucchesi wins New Entrepreneurs in Science and Technology (NETS) Prize.

Home | About ABMI | Clinical Focus | Monitoring Software | TCD Systems | Clinical Studies | News/Investors | Contact Us | Site Map


ABMI SA - 1 ch. des Vignes, 1026 Echandens (Switzerland) - Email: info@abmintelligence.com - Ph: +41 21 7014075 - Fax: +41 21 7014076 | info@abmintelligence.com

Back to content | Back to main menu